Currently, the focus of the medical world is pretty much on the Corona virus, but that is hardly the only medical threat to people. One of the more worrisome medical problems, have been antimicrobial resistance in bacterial pathogens, since it makes it harder and harder to treat things like tuberculosis.
Now, via ScienceDaily I see that the Wistar Institute has release a press release
Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR). These finding were published today in Nature.
The World Health Organization (WHO) has declared AMR as one of the top 10 global public health threats against humanity. It is estimated that by 2050, antibiotic-resistant infections could claim 10 million lives each year and impose a cumulative $100 trillion burden on the global economy. The list of bacteria that are becoming resistant to treatment with all available antibiotic options is growing and few new drugs are in the pipeline, creating a pressing need for new classes of antibiotics to prevent public health crises.
This is definitely good news, even if it is quite a way before it will be ready for general use.
When I clicked the link to the article in the Wistar press release, I was provided free access to the article, which was a pleasant surprise. I guess this is due to it being a health related article, which might mean that it was accessible due to the general agreement to let COVID-19 related articles be freely available across all medicial journals. I hope this can create some kind of precedence for health-related, and other subject of general public interest, articles in scientific and medical journal becoming available for free.